Ibuprofen | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ibuprofen
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ibuprofen

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

94 API Suppliers, 60 USDMF, 13 CEP/COS, 4 JDMF, 6 EU WC, 91 KDMF, 37 NDC API, 36 Listed Suppliers, $ API Reference Price

94 API Suppliers
60 USDMF
13 CEP/COS
4 JDMF
6 EU WC
91 KDMF
37 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

1118 FDF Dossiers, 318 FDA Orange Book, 332 Europe, 82 Canada, 15 Australia, 116 South Africa, 255 Listed Dossiers

1118 FDF Dossiers
318 FDA Orange Book
332 Europe
82 Canada
15 Australia
116 South Africa
255 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 200MG, TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT, SUSPENSION;ORAL - 100MG/5ML, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT, TABLET;ORAL - 38MG;200MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, TABLET;ORAL - 200MG;10MG

TABLET;ORAL - 200MG
TABLET;ORAL - 200MG
TABLET;ORAL - 200MG;30MG
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT
SUSPENSION;ORAL - 100MG/5ML
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG
CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT
TABLET;ORAL - 38MG;200MG
TABLET;ORAL - 2MG;200MG;30MG
TABLET;ORAL - 4MG;200MG;10MG
TABLET;ORAL - 200MG;10MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 19 DKSH, 2 Jai Radhe Sales, 3 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 16 Gangwal Healthcare, 2 Kewpie Corporation, 15 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 4 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

131 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 58 Direct Compression, 50 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 43 Solubilizers, 38 Controlled & Modified Release, 35 Parenteral, 35 Granulation, 34 Film Formers & Plasticizers, 34 Topical, 33 Taste Masking, 31 Lubricants & Glidants, 23 Co-Processed Excipients, 22 Chewable & Orodispersible Aids, 20 Emulsifying Agents, 13 API Stability Enhancers, 12 Rheology Modifiers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

131 Fillers, Diluents & Binders
63 Coating Systems & Additives
58 Direct Compression
50 Thickeners and Stabilizers
44 Disintegrants & Superdisintegrants
43 Solubilizers
38 Controlled & Modified Release
35 Parenteral
35 Granulation
34 Film Formers & Plasticizers
34 Topical
33 Taste Masking
31 Lubricants & Glidants
23 Co-Processed Excipients
22 Chewable & Orodispersible Aids
20 Emulsifying Agents
13 API Stability Enhancers
12 Rheology Modifiers
9 Empty Capsules
8 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 173 NEWS #PharmaBuzz

7 DATA COMPILATION #PharmaFlow
173 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 262 Finished Drug Prices

2 US Medicaid Prescriptions
262 Finished Drug Prices

MARKET PLACE

88 APIs, 38 FDF Dossiers

88 APIs
38 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 8 US Exclusivities, 4 Health Canada Patents

26 US Patents
8 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 27 Others

4 EDQM
2 USP
27 Others

ANALYTICAL

2 BioAnalytical Methods, 1 Analytical Methods

2 BioAnalytical Methods
1 Analytical Methods

$ API Ref.Price (USD/KG) : 12 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 1AFT PHARMS US

02 6CUMBERLAND PHARMS

03 1GLENMARK PHARMS LTD

filter Product Reset all filters

8 All

01 2ACETAMINOPHEN; IBUPROFEN

02 6IBUPROFEN

filter Exclusivity Expiration Date Reset all filters

8 All

01 12024-11-03

02 32024-11-19

03 12026-03-01

04 32026-05-11

filter Exclusivity Code Reset all filters

8 All

01 3M-128

02 1NP

03 3NPP

04 1PC

Product Main Page

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

1

Exclusivity Details

01

CUMBERLAND PHARMS

Pharma Manufacturing 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

1

Exclusivity Details

02

CUMBERLAND PHARMS

Pharma Manufacturing 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLENMARK PHARMS LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PC

Exclusivity Expiration Date

2024-11-03

Application Number

218311

Product Number

1

Exclusivity Details

03

GLENMARK PHARMS LTD

ACETAMINOPHEN; IBUPROFEN

euroPLX 86 Munich

Not Confirmed

GLENMARK PHARMS LTD

India

euroPLX 86 Munich

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : PC

Exclusivity Expiration Date : 2024-11-03

Application Number : 218311

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

AFT PHARMS US

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-03-01

Application Number

209471

Product Number

1

Exclusivity Details

04

AFT PHARMS US

ACETAMINOPHEN; IBUPROFEN

Pharma Manufacturing 2024

Not Confirmed

AFT PHARMS US

Country

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-03-01

Application Number : 209471

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

3

Exclusivity Details

05

CUMBERLAND PHARMS

Pharma Manufacturing 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

3

Exclusivity Details

06

CUMBERLAND PHARMS

Pharma Manufacturing 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

2

Exclusivity Details

07

CUMBERLAND PHARMS

Pharma Manufacturing 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

2

Exclusivity Details

08

CUMBERLAND PHARMS

Pharma Manufacturing 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

Pharma Manufacturing 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?